
Sign in to view content
Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration Across Key Clinical Trials
- Video
- Published 2018
Related
Category: Age-Related Macular Degeneration